SynthesisFrontiers in medicine2026

Prognostic value of interim post-treatment SPECT/CT following lutetium-177 (177Lu)-PSMA therapy in patients with metastatic castration-resistant prostate cancer: a systematic review and meta-analysis.

Amirreza Shamshirgaran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.